Uveitis Treatment Market PPT: Demand, Trends and Business Opportunities 2022-27

1
Global Uveitis Treatment Market Research and
Forecast Report 2022-2027




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Uveitis Treatment Market Research Report
2022-2027 The latest report by IMARC Group,
titled Uveitis Treatment Market Global Industry
Trends, Share, Size, Growth, Opportunity and
Forecast 2022-2027, finds that the global
uveitis treatment market size reached US
1.5 Billion in 2021. Uveitis refers to a
condition that causes inflammation of the middle
layer of tissue in the eyewall uvea. It causes
swelling that can damage the eye tissues, leading
to poor vision or blindness. Uveitis is mainly
caused by autoimmune diseases in which the body
attacks itself, causing inflammation, infection
and tumor in the eyes or other parts of the body.
The treatment for uveitis involves a
therapeutic process that can heal the
inflammation of the uvea and surrounding tissues.
It is treated with the help of drugs such as
cycloplegic agents, anti-inflammatory,
antimicrobials, as well as immunotherapy and
targeted therapies. Uveitis treatment also
provides the patient with relief from the pain,
prevents further damage of the tissues, and
restores vision loss. Request for a PDF sample
of this report https//www.imarcgroup.com/uveitis
-treatment-market/requestsample

4
Report Description and Highlights
Report Description
Global Uveitis Treatment Market Trends The
market is driven by the increasing prevalence of
uveitis and other infectious eye disorders in
individuals. Besides this, the growing awareness
regarding the need for proper treatment among
patients is also encouraging the adoption of
advanced therapeutics. In addition to this, the
rising complication associated with uveitis has
resulted in increased investment in healthcare,
thereby fueling the market growth. Furthermore,
individualswith diabetes, eye injuries,
cataracts, glaucoma, band keratopathy, and
inflammatory disorders are more susceptible to
uveitis. As a result, governments of different
nations are taking initiatives to accelerate the
approval of drugs in the pipeline and new routes
of drug administration to improve the efficacy of
the drugs. In addition to this, there has been
a rise in the number of clinical trials for eye
inflammation treatments for refractory posterior
and intermediate uveitis across the globe.
Nowadays, several leading manufacturers have
increased their production capacity of the
medication. Moreover, extensive research and
development (RD) activities in the field of
ophthalmology have led to the introduction
ofadvanced uveitis treatment, creating lucrative
opportunities in the market. Looking forward, the
market is expected to grow at a CAGR of 5.95
during the forecast period (2022-2027). View
Report TOC, Figures and Tables
https//www.imarcgroup.com/uveitis-treatment-marke
t

5
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Treatment Type
• Corticosteroids
• Immunosuppressant
• Monoclonal Antibodies
• Cycloplegic Agents
• Antibiotics
• Antivirals
• Antifungal
• Analgesics
•  
• Breakup by Disease Type
• Anterior Uveitis
• Posterior Uveitis
• Intermediate Uveitis
• Panuveitis

6
Report Description and Highlights
Report Description

•  
• Breakup by Cause
• Infectious
• Non-infectious
• Breakup by Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others
• Breakup by Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
•  

7
Report Description and Highlights
Report Description

•  
• Competitive Landscape with Key Players
• AbbVie Inc.
• Alimera Sciences Inc.
• Bausch Lomb Incorporated (Bausch Health)
• Enzo Biochem Inc.
• Eyegate Pharmaceuticals Inc.
• Eyepoint Pharmaceuticals Inc.
• Novartis AG
• Regeneron Pharmaceuticals Inc.
• Santen Pharmaceutical Co. Ltd.
•  

8
Key Questions Answered in the Report
Report Description

• How has the global uveitis treatment market
  performed so far and how will it perform in the
  coming years?
• What has been the impact of COVID-19 on the
  global uveitis treatment market?
• What are the key regional markets?
• What is the breakup of the market based on the
  treatment type?
• What is the breakup of the market based on the
  disease type?
• What is the breakup of the market based on the
  cause?
• What is the breakup of the market based on the
  distribution channel?
• What are the various stages in the value chain of
  the industry?
• What are the key driving factors and challenges
  in the industry?
• What is the structure of the global uveitis
  treatment market and who are the key players?
• What is the degree of competition in the
  industry?
•  

9
Table of Contents
Report Description
1    Preface2    Scope and Methodology    2.1
   Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3    Executive Summary4  
 Introduction    4.1    Overview    4.2    Key
Industry Trends5    Global Uveitis Treatment
Market    5.1    Market Overview    5.2  
 Market Performance    5.3    Impact of
COVID-19    5.4    Market Forecast

10
Table of Contents
Report Description
6    Market Breakup by Treatment Type    6.1  
 Corticosteroids        6.1.1 Market Trends   
    6.1.2 Market Forecast    6.2  
 Immunosuppressant        6.2.1 Market Trends 
      6.2.2 Market Forecast    6.3    Monoclonal
Antibodies        6.3.1 Market Trends       
6.3.2 Market Forecast    6.4    Cycloplegic
Agents        6.4.1 Market Trends        6.4.2
Market Forecast    6.5    Antibiotics       
6.5.1 Market Trends        6.5.2 Market
Forecast    6.6    Antivirals          Click
here to visit the complete table of content with
list of figures and tables https//www.imarcgroup
.com/uveitis-treatment-market/toc

11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
13
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
14

Contact Us